Literature DB >> 10951413

Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients.

D Y Kim1, H R Kim, J H Shim, C S Park, S K Kim, Y J Kim.   

Abstract

BACKGROUND AND OBJECTIVES: Carcinoembryonic antigen (CEA) has been widely accepted as a tumor marker useful in the diagnosis and management of colorectal carcinoma. When CEA levels are positive in patients with gastric carcinoma, they could be useful prognostic indicators. The value of CEA as a tumor marker for gastric carcinoma, however, remains a matter of controversy. The purpose of this study was to determine whether preoperative serum CEA value and tissue CEA staining are useful prognostic indicators for gastric carcinoma.
METHODS: We measured preoperative serum CEA levels by radioimmunoassay and stained tissue CEA production by tumor cells from gastric carcinomas using immunohistochemical staining in patients with gastric carcinoma.
RESULTS: The patients with preoperative serum CEA levels >10.0 ng/mL had a more prominent serosal invasion, much more lymph node involvement, more advanced stage and more poorly differentiated than did the patients with preoperative serum CEA levels <5.0 ng/mL. The survival rate of patients with serum CEA levels >10.0 ng/mL was poorer than those of patients with serum CEA levels between 5.0 and 10.0 ng/mL, and those of patients with serum CEA levels <5.0 ng/mL (P < 0.05). The preoperative serum CEA levels and tumor CEA-positivity were correlated (P < 0.05). In patients with lymph node metastases, the CEA-positivity (78.0%) was higher than in patients without lymph node metastasis (63.2%) (P < 0.05). A correlation was also found between the depth of tumor invasion and tissue CEA-positivity (P < 0.001). The postoperative survival rate was significantly better in the CEA-negative staining group (78.0%) than in the CEA-positive staining group (60.0%).
CONCLUSIONS: These data suggest that preoperative serum CEA levels and staining for CEA in gastric carcinoma tissue sections may have a predictive value in determining prognostic information for patients with resectable gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951413     DOI: 10.1002/1096-9098(200007)74:3<185::aid-jso4>3.0.co;2-0

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  18 in total

1.  Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.

Authors:  Wesam A Nasif; Mahmoud Lotfy; Ibrahim H El-Sayed; Ayman El-Meghawry El-Kenawy; Mohamed El-Shahat; Nabil Gad El-Hak
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.

Authors:  Ming-Ming He; Dong-Sheng Zhang; Feng Wang; Zhi-Qiang Wang; Hui-Yan Luo; Chao Ren; Ying Jin; Dong-Liang Chen; Rui-Hua Xu
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

3.  Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer.

Authors:  Tsutomu Namikawa; Yasuhiro Kawanishi; Kazune Fujisawa; Eri Munekage; Jun Iwabu; Masaya Munekage; Hiromichi Maeda; Hiroyuki Kitagawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Surg Today       Date:  2017-10-17       Impact factor: 2.549

4.  Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics.

Authors:  Yuan Tian; Zhihao Yao; Richard B S Roden; Hui Zhang
Journal:  Proteomics       Date:  2011-11-23       Impact factor: 3.984

5.  The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites.

Authors:  Minkyu Jung; Hei-Cheul Jeung; Sung Sook Lee; Jun Yong Park; Soojung Hong; Soo Hyeon Lee; Sung Hoon Noh; Hyun Cheol Chung; Sun Young Rha
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-23       Impact factor: 4.553

6.  A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland.

Authors:  Hong He; Guanfu Chen; Liang Zhou; Yanmin Liu
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-26       Impact factor: 4.553

Review 7.  Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.

Authors:  Hideaki Shimada; Tamaki Noie; Manabu Ohashi; Koji Oba; Yutaka Takahashi
Journal:  Gastric Cancer       Date:  2013-04-10       Impact factor: 7.370

Review 8.  Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 72-4 in Gastric Cancer: Is the Old Band Still Playing?

Authors:  Andrey Iskrenov Kotzev; Peter Vassilev Draganov
Journal:  Gastrointest Tumors       Date:  2018-04-24

9.  Clinical significance of circulating tumor cell related markers in patients with epithelial ovarian cancer before and after adjuvant chemotherapy.

Authors:  Meysam Yousefi; Sara Rajaie; Vahideh Keyvani; Somayeh Bolandi; Malihe Hasanzadeh; Alireza Pasdar
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

10.  Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis.

Authors:  M Terashima; C Maesawa; K Oyama; S Ohtani; Y Akiyama; S Ogasawara; A Takagane; K Saito; T Masuda; N Kanzaki; S Matsuyama; Y Hoshino; M Kogure; M Gotoh; M Shirane; K Mori
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.